Saturday, April 15, 2017
23andMe given green light to sell DNA for 10 diseases
The FDA has now allowed 23andMe to market for tests for 10 genetic conditions including Alzheimer's and Parkinson’s diseases, coeliac disease and thrombophilia. Until 2013, the company offered DNA testing for certain medical conditions, but the FDA ordered 23andMe to halt the service out of concern users would take the results as medical advice. This genetic testing is not equivalent to a medical diagnosis, because environment, personal health and family history all affect risk of developing a disease. This appears to be a step in the right direction for an improvement in healthcare, and while this test is not provided by a physician or genetic counselor, it will give people further information about any potential medical conditions.